These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8309842)

  • 21. Current and future nonhormonal approaches to the treatment of osteoporosis.
    Bilezikian JP
    Int J Fertil Menopausal Stud; 1996; 41(2):148-55. PubMed ID: 8829694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of immobilization-induced osteoporosis with human calcitonin].
    Nogarin L; Magnan B; Boscaro C; Lazzaretto R; Ambroso B
    G Clin Med; 1987 Jan; 68(1):17-20. PubMed ID: 3609593
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K; Josse RG
    CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic strategies for osteoporosis].
    Chapurlat R; Delmas PD
    Ann Med Interne (Paris); 2000 Oct; 151(6):471-6. PubMed ID: 11104926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of osteoporosis with thyrocalcitionin].
    Milhaud G; Bloch-Michel H
    Therapeutique; 1971 May; 47(5):517-8. PubMed ID: 5105540
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness of thyrocalcitonin in the treatment of steroid-induced osteoporosis.
    Briskin AI; Dubrov EIa; Strizhakova LL
    Klin Med (Mosk); 1976 Nov; 54(11):80-4. PubMed ID: 1034173
    [No Abstract]   [Full Text] [Related]  

  • 28. [Osteocalcin (BGP) values in postmenopausal osteoporosis before and after treatment with calcitonin].
    Rico H; Cabranes JA; Núñez-Torrón M; Higueras JC; Hernández ER
    Med Clin (Barc); 1986 May; 86(19):791-3. PubMed ID: 3488474
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of alendronate, calcitonin and calcium treatments in postmenopausal osteoporosis.
    Dursun N; Dursun E; Yalçin S
    Int J Clin Pract; 2001 Oct; 55(8):505-9. PubMed ID: 11695068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in osteoporosis therapy. 2003 update of practical guidelines.
    Khan A
    Can Fam Physician; 2003 Apr; 49():441-7. PubMed ID: 12729240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of thyrocalcitonin in age induced osteoporosis].
    Vasiukova EA; Kochergina II
    Klin Med (Mosk); 1971 Sep; 49(9):101-4. PubMed ID: 5112684
    [No Abstract]   [Full Text] [Related]  

  • 32. Results of special studies with alendronate.
    McClung M
    Int J Clin Pract Suppl; 1999 Apr; 101():67-72. PubMed ID: 12669743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of osteoporosis with antiresorptive drugs].
    Vestergaard P; Mosekilde L; Brixen K
    Ugeskr Laeger; 2005 Feb; 167(8):883-7. PubMed ID: 15789840
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term treatment with thyrocalcitonin in senile osteoporosis: studies with radio-calcium].
    Caniggia A; Gennari C; Bencini M; Cesari L; Borrello G
    Boll Soc Ital Biol Sper; 1970 Jan; 46(2):86-8. PubMed ID: 5419776
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnosis and pharmacologic therapy of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Jul; 144(28):1373-9. PubMed ID: 12914121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience with porcine thyrocalcitonin in the treatment of senile osteoporosis].
    Boni A
    Clin Ter; 1980 Aug; 94(3):325-34. PubMed ID: 7449349
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term treatment with thyrocalcitonin in senile osteoporosis: metabolic aspects].
    Caniggia A; Gennari C; Bencini M; Cesari L; Borrello G
    Boll Soc Ital Biol Sper; 1970 Jan; 46(2):85-6. PubMed ID: 5419775
    [No Abstract]   [Full Text] [Related]  

  • 38. [Calcitonin. Physiology and therapeutic uses].
    Mautalen CA; González D
    Medicina (B Aires); 1991; 51(3):257-65. PubMed ID: 1821910
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment options in osteoporosis.
    Seal R
    Community Nurse; 1997 Jan; 2(11):21-2. PubMed ID: 9451092
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of calcitonin tolerance after intramuscular or intranasal administration in treatment for postmenopausal osteoporosis].
    Horst-Sikorska W; Ruszkowska J; Kosowicz J
    Przegl Lek; 1996; 53(1):9-11. PubMed ID: 8711177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.